Literature DB >> 8492712

Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein.

R Germinario1, A D Sniderman, S Manuel, S P Lefebvre, A Baldo, K Cianflone.   

Abstract

Acylation-stimulating protein (ASP) is the most potent recognized stimulant of triacylglycerol synthesis in human adipocytes. However, its mechanism(s) of action have not yet been elucidated in detail. The present study examines the effects of ASP on membrane transport of glucose and fatty acids in cultured human skin fibroblasts. The data demonstrate that ASP stimulated carrier-mediated glucose transport in a time- and concentration-dependent manner, an effect that was greater than and independent of that observed with insulin. ASP increased the Vmax for glucose transport with no change in the transport Km, suggesting that ASP might result in increased sugar transporters in the plasma membrane. This finding was supported by quantitative Western blot analyses using a monoclonal antibody (G3) that demonstrated an increase in the plasma membrane content of the glucose transporter (Glut 1) with a concomitant decrease in the glucose transporter content of an intracellular membrane fraction. By contrast, ASP had no effect on specific membrane transport of fatty acids. Maximal effects of ASP on triacylglycerol synthesis were demonstrated at saturating levels of both glucose and oleate. Comparable stimulation by ASP in the absence of glucose (with or without pyruvate) was also demonstrated, although the absolute rates of triacylglycerol synthesis were substantially lower. Finally, it was shown that ASP increased the apparent Vmax for triglyceride synthesis without changing its Km. Since ASP will act in the absence of extracellular glucose, ASP must have additional actions, independent of its effect on specific membrane transport of glucose by which it accelerates intracellular triglyceride synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492712     DOI: 10.1016/0026-0495(93)90215-a

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  22 in total

Review 1.  Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes.

Authors:  Olusola Olalekan Elekofehinti; Idowu Olaposi Omotuyi; Jean Paul Kamdem; Oluwamodupe Cecilia Ejelonu; Guimarae Vanessa Alves; Isaac Gbadura Adanlawo; João Batista Teixeira Rocha
Journal:  J Physiol Biochem       Date:  2014-02-25       Impact factor: 4.158

2.  Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population.

Authors:  Ying-Ying Zheng; Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Zhen-Yan Fu; Xiao-Mei Li; Xiang Ma; Bang-Dang Chen; Fen Liu
Journal:  Endocrine       Date:  2011-12-18       Impact factor: 3.633

Review 3.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients.

Authors:  Francesco Ursini; Alessandro Grembiale; Saverio Naty; Rosa Daniela Grembiale
Journal:  Clin Rheumatol       Date:  2013-09-05       Impact factor: 2.980

5.  Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.

Authors:  I Murray; J Köhl; K Cianflone
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

6.  The Structural Basis of Action of Vanadyl (VO2+) Chelates in Cells.

Authors:  Marvin W Makinen; Marzieh Salehitazangi
Journal:  Coord Chem Rev       Date:  2014-11-01       Impact factor: 22.315

7.  Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells.

Authors:  K Sivakumar; M F Bari; A Adaikalakoteswari; S Guller; M O Weickert; H S Randeva; D K Grammatopoulos; C C Bastie; M Vatish
Journal:  J Clin Endocrinol Metab       Date:  2013-08-16       Impact factor: 5.958

8.  Surrogate markers of insulin resistance: A review.

Authors:  Bhawna Singh; Alpana Saxena
Journal:  World J Diabetes       Date:  2010-05-15

9.  The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice.

Authors:  Sabina Paglialunga; Alexandre Fisette; Mercedes Munkonda; Ying Gao; Denis Richard; Katherine Cianflone
Journal:  BMC Physiol       Date:  2010-04-23

10.  Role of protease inhibitors and acylation stimulating protein in the adipogenesis in 3T3-L1 cells.

Authors:  Mohamed Mohamed Soliman; Yakut Abdel-Fattah El-Senosi; Maysara Mahmoud Salem; Omniya Mahmoud Abdel Hamid; Kimura Kazuhiro
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.